Androgen receptor as potential therapeutic target in metastatic endometrial cancer-Reference-Cited by-同舟云学术

Androgen receptor as potential therapeutic target in metastatic endometrial cancer

Published:2016-06-30 Issue:31 Volume:7 Page:49289-49298
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tangen Ingvild Løberg¹²,Onyango Therese Bredholt¹²,Kopperud Reidun¹²,Berg Anna¹²,Halle Mari K.¹²,Øyan Anne M.³⁴,Werner Henrica M.J.¹²,Trovik Jone¹²,Kalland Karl Henning³⁴,Salvesen Helga B.¹²,Krakstad Camilla²⁵

Affiliation:

1. Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Norway

2. Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway

3. Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Norway

4. Department of Microbiology, Haukeland University Hospital, Norway

5. Centre for Cancer Biomarkers, Department of Biomedicine, University of Bergen, Norway

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-receptor regulation of 11-oxyandrogens differs between normal and cancerous endometrium and across endometrial cancer grades and molecular subtypes;Frontiers in Endocrinology;2024-08-14

2. Androgen-responsive FOXP4 is a target for endometrial carcinoma;Communications Biology;2024-06-18

3. Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy;Cancers;2024-05-27

4. Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineages;2024-05-14

5. Discovering common pathogenetic processes between polycystic ovary syndrome and uterine corpus endometrial carcinoma by bioinformatics and experimental approach;Arabian Journal of Chemistry;2024-02